ConductScience.org, home

Paper6721995

Rifampicin kinetics in undernutrition.

Polasa K and 2 others. Br J Clin Pharmacol, 1984. Cited by 37 papers, by iCite.

Cite this record

ConductScience Library. Rifampicin kinetics in undernutrition. Papers, record 6721995. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/6721995

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Rifampicin kinetics in undernutrition.
PubMed
Journal
Br J Clin Pharmacol
PubMed
Year
1984
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
37
iCite
Relative citation ratio, by iCite
1.48
iCite
Revised in PubMed
2019-05-11
PubMed

Authors3

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Polasa KK
2Murthy KJK J
3Krishnaswamy KK

Source PubMed

Download CSV of authors

Topics9

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Nutrition DisordersMajor topic
RifampinMajor topic
Biological Assay
Blood Proteins
Hemoglobins
Humans
Kinetics
Protein Binding
Tuberculosis, Pulmonary

Source PubMed

Download CSV of topics

References8

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
14991572[Renal clearance of rifampicin].J Urol Nephrol (Paris)1970https://conductscience.org/library/papers/4991572PubMed
24673866A survey of diabetes mellitus in a rural population of India.Diabetes1972https://conductscience.org/library/papers/4673866PubMed
34153424Optimized determination of gamma-glutamyltransferase by reaction-rate analysis.Clin Chem1974https://conductscience.org/library/papers/4153424PubMed
4684036Multicompartmental analysis of serum, urine and bile concentrations of rifampicin and desacetyl-rifampicin in subjects treated for one week.Pharmacol Res Commun1978https://conductscience.org/library/papers/684036PubMed
5334439Nutrition and drug-metabolizing enzymes.Clin Pharmacol Ther1977https://conductscience.org/library/papers/334439PubMed
6346286Clinical pharmacokinetics of rifampicin.Clin Pharmacokinet1978https://conductscience.org/library/papers/346286PubMed
7350472Drug metabolism and pharmacokinetics in malutrition.Clin Pharmacokinet1978https://conductscience.org/library/papers/350472PubMed
81248917Investigation on the serum and lung tissue level of rifampicin in man.Int J Clin Pharmacol Biopharm1976https://conductscience.org/library/papers/1248917PubMed

Download CSV of references

Cited by21

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 37 citations.

PMIDTitleJournalYearIn PapersSource
40608197Rifampicin Exposure in Tuberculosis Patients with Comorbidities in Sub-Saharan Africa: Prioritising Populations for Treatment-A Systematic Review and Meta-analysis.Clin Pharmacokinet2025https://conductscience.org/library/papers/40608197PubMed
39312270Plasma and urinary CP I and CP III concentrations in chimeric mice with human hepatocytes after rifampicin administration.Pharmacol Res Perspect2024https://conductscience.org/library/papers/39312270PubMed
39240337Therapeutic drug monitoring in tuberculosis.Eur J Clin Pharmacol2024https://conductscience.org/library/papers/39240337PubMed
38315168Variability in plasma rifampicin concentrations and role of SLCO1B1, ABCB1, AADAC2 and CES2 genotypes in Ethiopian patients with tuberculosis.Infect Dis (Lond)2024https://conductscience.org/library/papers/38315168PubMed
34060020Influence of Malnutrition on the Pharmacokinetics of Drugs Used in the Treatment of Poverty-Related Diseases: A Systematic Review.Clin Pharmacokinet2021https://conductscience.org/library/papers/34060020PubMed
33951066Nutritional markers and proteome in patients undergoing treatment for pulmonary tuberculosis differ by geographic region.PLoS One2021https://conductscience.org/library/papers/33951066PubMed
33126298Effect of interval between food intake and drug administration at fasting condition on the plasma concentrations of first-line anti-tuberculosis drugs in Chinese population.Medicine (Baltimore)2020https://conductscience.org/library/papers/33126298PubMed
31694244Development and Evaluation of Physiologically Based Pharmacokinetic Drug-Disease Models for Predicting Rifampicin Exposure in Tuberculosis and Cirrhosis Populations.Pharmaceutics2019https://conductscience.org/library/papers/31694244PubMed
31332668Clinical Significance of the Plasma Protein Binding of Rifampicin in the Treatment of Tuberculosis Patients.Clin Pharmacokinet2019https://conductscience.org/library/papers/31332668PubMed
31246958Mid-upper arm circumference predicts death in adult patients admitted to a TB ward in the Philippines: A prospective cohort study.PLoS One2019https://conductscience.org/library/papers/31246958PubMed
31049868Clinical Pharmacokinetics and Pharmacodynamics of Rifampicin in Human Tuberculosis.Clin Pharmacokinet2019https://conductscience.org/library/papers/31049868PubMed
29735566Protein Binding of First-Line Antituberculosis Drugs.Antimicrob Agents Chemother2018https://conductscience.org/library/papers/29735566PubMed
25801554Exposure to total and protein-unbound rifampin is not affected by malnutrition in Indonesian tuberculosis patients.Antimicrob Agents Chemother2015https://conductscience.org/library/papers/25801554PubMed
24709267Nutritional supplementation increases rifampin exposure among tuberculosis patients coinfected with HIV.Antimicrob Agents Chemother2014https://conductscience.org/library/papers/24709267PubMed
23629715Pharmacokinetics of first-line tuberculosis drugs in Tanzanian patients.Antimicrob Agents Chemother2013https://conductscience.org/library/papers/23629715PubMed
22411614Reduced antituberculosis drug concentrations in HIV-infected patients who are men or have low weight: implications for international dosing guidelines.Antimicrob Agents Chemother2012https://conductscience.org/library/papers/22411614PubMed
16569826Determinants of rifampin, isoniazid, pyrazinamide, and ethambutol pharmacokinetics in a cohort of tuberculosis patients.Antimicrob Agents Chemother2006https://conductscience.org/library/papers/16569826PubMed
12126459Pharmacokinetic interactions between efavirenz and rifampicin in HIV-infected patients with tuberculosis.Clin Pharmacokinet2002https://conductscience.org/library/papers/12126459PubMed
8978236Grand rounds--Hammersmith Hospital. Persistent fever in pulmonary tuberculosis.BMJ1996https://conductscience.org/library/papers/8978236PubMed
3135137Influences of diet and nutrition on clinical pharmacokinetics.Clin Pharmacokinet1988https://conductscience.org/library/papers/3135137PubMed

See all 21 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/6721995

GET https://conductscience.org/api/papers/v1/6721995/cited_by?page=2